News

2008-09-17 The ceremony of signing the agreement for funding R&D project

The project for developing a Polish innovative drug to be used in treating schizophrenia, depression and anxiety, led by our company in cooperation with Jagiellonian University Collegium Medicum and the Institute of Psychiatry and Neurology in Warsaw has received 16,4 million PLN funding from state budget for science. The ceremony during which the agreement for funding was signed, took place on September 5th at the National Research and Development Centre.

Joint research is conducted by a team of 50 researchers from Jagiellonian University Collegium Medicum, the Institute of Psychiatry and Neurology in Warsaw and Adamed's research and development departments. "Developing a Polish drug as therapy for central nervous system diseases: schizophrenia, depression and anxiety - preclinical trials" project will run for almost 4 years. Work will be partially financed by the state as part of the "Technology Initiative I" program of the Minister of Science and Higher Education.
The research program coordinated by Adamed is the first of its kind of initiative in Poland. It includes developing a new psychotropic substance, from defining biological aims, design and synthesis of the chemical compound libraries to initial pharmacological and toxicological tests up to advanced preclinical trials, which are to confirm the efficacy and safety of the potential drug.
The first phase of developing the drug is evaluation of in vitro activity (biochemical tests) which will be completed in 2009, however at the end of this year commencement of in vivo testing is planned. The next step (planned for 2010-2012) will be advanced pharmacological and toxicological testing, conducted in accordance with Good Laboratory Practice standards, aimed at singling out the best compounds for clinical trials.
Present at the ceremony of agreement execution whereby financing will be awarded by the government in the amount of 16,4 million PLN were among others: Prof Boguslaw Smolski, Director of the National Research and Development Centre, Prof Maciej Pawlowski from Jagiellonian University Collegium Medicum, Prof Przemyslaw Bienkowski from the Institute of Psychiatry and Neurology in Warsaw as well as Adamed's Chairman of the Board Maciej Adamkiewicz along with representatives of research centres and universities participating in the project. Representatives of prestigious research centres in Poland were also present during the ceremony.
Prior to the official signing, presentations were given showing research results from some of the universities. One of the most important elements of the whole event was the presentation of our research and development laboratories in which part of the project will be realized.
Source: M. Czerepak